Stefan Braam
Papers
1
Total Citations
1
H-Index
1
About
Stefan Braam is a pioneering researcher at the intersection of stem cell biology, cardiac disease modeling, and high-throughput drug discovery. His work centers on leveraging human induced pluripotent stem cell (hiPSC)-derived cardiac microtissues to recapitulate inherited arrhythmia disorders in vitro, enabling the identification of novel therapeutic compounds. Braam’s most notable contribution is his 2025 study on high-throughput drug screening using 3D hiPSC cardiac microtissues, which demonstrates a scalable platform for testing potential treatments for genetic arrhythmias. This approach bridges the gap between traditional 2D cell culture and animal models, offering a more physiologically relevant system for preclinical drug evaluation. Although his citation count is still growing, his work has already garnered attention for its translational potential, particularly in personalized medicine for cardiac patients. Braam’s research is distinguished by its integration of advanced tissue engineering, stem cell technology, and automated screening, positioning him as an emerging leader in cardiovascular pharmacology. His achievements highlight a commitment to developing safer, more effective therapies for inherited heart conditions, making his work essential reading for students and researchers in regenerative medicine and drug development.
Research Focus
Key Achievements
Top Papers
- 1